×
0 0 0 0 0 0.00172253875712216 0.000397508943951254 0.00172253875712216
Stockreport

Gilead's Vemlidy OK'd in Europe [Seeking Alpha]

GILEAD SCIENCES (GILD)  More Company Research Source: Seeking Alpha
Last gilead sciences earnings: 10/26 04:01 pm Check Earnings Report
PDF </header> As expected, the ACORN:3080131534 European Commission approves NASDAQ-NMS:GILD Gilead Sciences' (NASDAQ: GILD ) Vemlidy (tenofovir alafenamide, TAF) 25 mg, a once-daily tablet for the treatment of chronic hepatitis B virus (HBV) infecti [Read more]

IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

-4.51%

GILD's stock demonstrates unremarkable cutback of -4.51% from 75.47-share to 72.07-share since news was released

EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS